PAI-039 treatment increased active uPA and matrix metalloproteinase-9 (MMP-9) levels in Akita mouse tibialis anterior (TA) muscles, supporting the hypothesis that PAI-1 suppresses the proteolytic activity of uPA and MMP-9 in diabetes, thereby impairing the regenerative process [2]. This evidence concerns the gene MMP9 and diabetes mellitus.